Skip to main content

Event Details

Summit Therapeutics Presents at TD Cowen's 46th Annual Health Care Conference

March 2, 2026 2:30 PM ET

*Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA).

© Summit Therapeutics Inc.

Trademarks, Registered or Otherwise, are the property of their respective owner(s).